Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
726.9 EUR | +5.78% | +5.58% | +38.06% |
May. 01 | Amgen investors await weight-loss drug data | RE |
May. 01 | Danish Medicines Agency Says Type 2 Diabetes Patients Should Start Treatment With 'Cheaper' Drugs | MT |
Sales 2024 * | 43.17B 40.28B | Sales 2025 * | 51.95B 48.47B | Capitalization | 699B 653B |
---|---|---|---|---|---|
Net income 2024 * | 12.03B 11.22B | Net income 2025 * | 16.09B 15.01B | EV / Sales 2024 * | 16.7 x |
Net Debt 2024 * | 20.93B 19.52B | Net Debt 2025 * | 13.85B 12.92B | EV / Sales 2025 * | 13.7 x |
P/E ratio 2024 * |
57.4
x | P/E ratio 2025 * |
42.8
x | Employees | 43,000 |
Yield 2024 * |
0.67% | Yield 2025 * |
0.77% | Free-Float | 99.83% |
Latest transcript on Eli Lilly and Company
1 day | +5.78% | ||
1 week | +5.58% | ||
Current month | +0.33% | ||
1 month | +0.33% | ||
3 months | +22.17% | ||
6 months | +37.15% | ||
Current year | +38.06% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Anat Ashkenazi
DFI | Director of Finance/CFO | 51 | 00-12-31 |
Ruth Gimeno
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 726.9 | +5.78% | 717 |
24-04-29 | 687.2 | +0.12% | 780 |
24-04-26 | 686.4 | +1.39% | 542 |
24-04-25 | 677 | -1.02% | 556 |
24-04-24 | 684 | -1.34% | 375 |
Delayed Quote Deutsche Boerse AG, April 30, 2024 at 03:26 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B | |
-5.59% | 154B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock